At NexaGen, patient safety isn't just a commitment — it's the foundation of everything we do. From rigorous clinical trials to comprehensive post-market surveillance, we work tirelessly to ensure our therapies meet the highest standards of safety and efficacy.
NexaGen maintains industry-leading safety protocols at every stage of drug development.
Every NexaGen therapy undergoes comprehensive Phase 1, 2, and 3 clinical trials involving thousands of patients. Our studies are designed to the highest scientific standards and monitored by independent Data Safety Monitoring Boards.
We are committed to full regulatory transparency. All adverse events are promptly reported to the FDA and other regulatory agencies. Our clinical trial data is available through ClinicalTrials.gov and published in peer-reviewed journals.
Our pharmacovigilance team monitors every NexaGen therapy long after approval. We actively track real-world outcomes, analyze patient feedback, and work with healthcare providers to ensure optimal treatment outcomes.
We believe patients are partners in their healthcare journey. Our Patient Affairs team provides comprehensive support, answers questions, and ensures every patient has access to the information they need.
If you are currently taking Serenix®, please continue your prescribed treatment regimen. Do not discontinue any medication without first consulting your healthcare provider.
Serenix® has helped millions of patients manage anxiety and depression since its FDA approval in 2041. Like all medications, Serenix® has benefits and risks that you should discuss with your doctor.
If you experience any unexpected symptoms while taking Serenix® or any NexaGen medication, please contact your healthcare provider or call our medical information hotline at 1-800-NEXAGEN.
Your feedback helps us maintain the highest safety standards.
NexaGen takes all reports of adverse events seriously. If you or a patient has experienced an unexpected side effect while taking a NexaGen medication, please report it using one of the following methods:
1-800-NEXAGEN
(1-800-639-2436)
Available 24/7
You may also report adverse events directly to the FDA through MedWatch, the FDA Safety Information and Adverse Event Reporting Program.
Our manufacturing facilities meet or exceed all FDA, EMA, and international regulatory standards. Every batch of every NexaGen medication is tested to ensure purity, potency, and consistency.
Our commitment to quality means you can trust that every NexaGen therapy meets the standards you deserve.
Our Patient Affairs team is available to answer your questions and provide support
